Chemodex

Prostaglandin F2α tromethamine salt

As low as CHF 116.00
In stock
Only %1 left
CDX-P0320-M0055 mgCHF 116.00
CDX-P0320-M01010 mgCHF 142.00
CDX-P0320-M02525 mgCHF 284.00
NEW
 
More Information
Product Details
Synonyms Dinoprost trometamol; PGF2α tromethamine; Prostaglandin F2α THAM salt; Prostaglandin F2α tris salt; Lutalyse; U 14583E; NSC 196515; Minprostin F2α; Enzaprost T
Product Type Chemical
Properties
Formula C20H34O5 . C4H11NO3
MW 475.62
CAS 38562-01-5
Source/Host Chemicals Synthetic
Purity Chemicals ≥99% (TLC)
Appearance White to off-white powder.
Solubility Soluble in DMSO, ethanol or methanol (all 50 mg/ml).
Identity Determined by 1H-NMR.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key IYGXEHDCSOYNKY-RZHHZEQLSA-N
Smiles OC(CCC/C=C\C[C@@H]1[C@H]([C@@H](C[C@@H]1O)O)/C=C/[C@@H](O)CCCCC)=O.OCC(CO)(N)CO
Shipping and Handling
Shipping AMBIENT
Short Term Storage -20°C
Long Term Storage -20°C
Handling Advice Protect from light and moisture.
Use/Stability Stable for at least 2 years after receipt when stored at -20°C.
Documents
Product Specification Sheet
Datasheet Download PDF
Description
Prostaglandin F2α (PGF2α) is a widely distributed prostaglandin occurring in many species. It causes contraction of vascular, bronchial, intestinal, and myometrial smooth muscle, and also exhibits potent luteolytic activity. Mechanistically, it acts via activation of the FP (prostaglandin F2α) receptor to raise intracellular calcium, driving smooth muscle contraction and facilitating luteolysis. This makes it a versatile agent both for controlled reproductive interventions and as a key tool in physiological and pharmacological research. PGF2α exhibits its receptor mediated physiological activity at 50-100nM.
Product References
(1) L. Speroff & P.W. Ramwell; Am. J. Obstet. Gynecol. 107, 1111 (1970) | (2) B. Samuelsson, et al.; Annu. Rev. Biochem. 47, 997 (1978) | (3) K. Watanabe, et al.; PNAS 83, 1583 (1986) | (4) D.J. Crankshaw & V. Gaspar; J. Reprod. Fertil. 103, 55 (1995) | (5) C.W. Miller, et al.; Endocrinol. 137, 5641 (1996) | (6) F.J. Diaz, et al.; Mol. Cell Endocrinol. 191, 65 (2002) | (7) S. Basu; Med. Res. Rev. 27, 435 (2007) | (8) D. Agas, et al.; J. Cell Physiol. 228, 25 (2013) | (9) J. Kim & M. Shim; Biochim. Biophys. Acta 1853, 500 (2015) | (10) E. Goupil, et al.; J. Biol. Chem. 290, 3137 (2015)
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.